Expect tighter cargo screening; IBM sees barcodes but not RFID in fakes fighting;

> The recent terrorism attempt that involved UPS and Fed Ex will likely soon lead to tighter air cargo screening requirements, but still short of the 100 percent requirement now in force for cargo on passenger airlines. News

> Barcodes and sensors are part of IBM's vision for drug tracking; no mention of RFID. Story/video

> Drugmakers need to be watching the FDA's attempts to change the medical device clearance process, which would let the regulator make major reforms without congressional approval. Article

> The FDA has increased inspections of foreign drug plants and begun to improve the data it keeps on them, but it needs to do more. GAO report

> Pennsylvania has pitched in $4.7 million to persuade Teva Pharmaceuticals to locate a distribution center in Philadelphia. Report

> Startup 3PL OM Healthcare Logistics has signed a five-year deal with CareFusion (San Diego), the spinout from Cardinal Health that is also about a year old. Article

> A cyclotron for generating radioactively tagged isotopes, nine hot cell labs for processing them into vials and syringes, and a 4,000-square-foot cGMP lab for producing clinical trial supplies are part of the new Methodist Hospital Research Institute (TMHRI) in Houston. TMHRI release

> Agilent Technologies has opened a facility in Singapore for manufacturing Liquid Chromatography/Mass Spectrometry (LC/MS) instruments and other life sciences instruments. Agilent release

> Phambili-Dismed, South Africa's largest black-owned pharma manufacturer, is building a $14 million factory for making IV solutions and hygiene products, thanks to funding from the Industrial Development Corporation. Article

> India-based generics maker Aurobindo is expanding its operations in Malta. News

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.